Please assess the completion status of the following clinical trial:

Trial Title: Treatment Duration for Abdominal Tuberculosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Newly diagnosed patients with Intestinal TB or Peritoneal TB~* Has not received ATT for Tuberculosis any where in the body during past 5 years~* Patients having good general health and not too sick.~* Patients willing and likely to comply with the study procedures and follow up~* Patients should give informed consent.~Exclusion Criteria:~* Eighteen year is a cut off age for definition of adult and pediatric and adolescent medicine. The dosing of drugs are different in these two age groups. Therefore we plan to include patients of more than 18 years of age with abdominal TB in this study.~* Intake of ATT during the past 5 years~* Doubtful diagnosis~* Crohn's disease~* Patients with HIV and AIDS may have another systemic opportunistic infections including GI infections like cryptosporidiosis, Microsporidiosis or isosporiasis. There may be an overlap of GI manifestations such as diarrhea, abdominal pain, anemia, fever. Therefore, assessment of response to anti-tuberculosis therapy may be blurred. In order to keep the study group homogenous for comparison, we plan to exclude all those with HIV infection~* Chronic Liver Disease~* Associated significant co-morbidities~* H/O Sensitivity~* Peritoneal carcinomatosis~* Patients must not been used investigational agents during the past 6 months~* Unwilling patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1: Category I treatment for 6 months (Type: ACTIVE_COMPARATOR): Anti-tuberculosis drugs
- Arm 2: Category I treatment for 9 months (Type: ACTIVE_COMPARATOR): Anti-tuberculosis drugs,

Based on this trial design, predict the completion outcome and termination type (if applicable).